208 related articles for article (PubMed ID: 24766737)
1. ShaoYao decoction ameliorates colitis-associated colorectal cancer by downregulating proinflammatory cytokines and promoting epithelial-mesenchymal transition.
Lin X; Yi Z; Diao J; Shao M; Zhao L; Cai H; Fan Q; Yao X; Sun X
J Transl Med; 2014 Apr; 12():105. PubMed ID: 24766737
[TBL] [Abstract][Full Text] [Related]
2. Shenling Baizhu San supresses colitis associated colorectal cancer through inhibition of epithelial-mesenchymal transition and myeloid-derived suppressor infiltration.
Lin X; Xu W; Shao M; Fan Q; Wen G; Li C; Jing L; Sun X
BMC Complement Altern Med; 2015 Apr; 15():126. PubMed ID: 25897964
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of Shaoyao Decoction against colorectal cancer via the Keap1-Nrf2-ARE signaling pathway.
Wang X; Saud SM; Zhang X; Li W; Hua B
J Ethnopharmacol; 2019 Sep; 241():111981. PubMed ID: 31146002
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of ShaoYao decoction on colitis-associated colorectal cancer by inducing Nrf2 signaling pathway.
Wang X; Saud SM; Wang F; He S; Zhang X; Hua B; Li W
J Ethnopharmacol; 2020 Apr; 252():112600. PubMed ID: 31981745
[TBL] [Abstract][Full Text] [Related]
5. Shaoyao decoction attenuates DSS-induced ulcerative colitis, macrophage and NLRP3 inflammasome activation through the MKP1/NF-κB pathway.
Wei YY; Fan YM; Ga Y; Zhang YN; Han JC; Hao ZH
Phytomedicine; 2021 Nov; 92():153743. PubMed ID: 34583225
[TBL] [Abstract][Full Text] [Related]
6. miR-370-3p Alleviates Ulcerative Colitis-Related Colorectal Cancer in Mice Through Inhibiting the Inflammatory Response and Epithelial-Mesenchymal Transition.
Lin L; Wang D; Qu S; Zhao H; Lin Y
Drug Des Devel Ther; 2020; 14():1127-1141. PubMed ID: 32214798
[TBL] [Abstract][Full Text] [Related]
7. Blocking NFATc3 ameliorates azoxymethane/dextran sulfate sodium induced colitis-associated colorectal cancer in mice via the inhibition of inflammatory responses and epithelial-mesenchymal transition.
Lin Y; Koumba MH; Qu S; Wang D; Lin L
Cell Signal; 2020 Oct; 74():109707. PubMed ID: 32653643
[TBL] [Abstract][Full Text] [Related]
8. Shaoyao Decoction Inhibits Inflammation and Improves Intestinal Barrier Function in Mice With Dextran Sulfate Sodium-Induced Colitis.
Chi H; Wang D; Chen M; Lin J; Zhang S; Yu F; Zhou J; Zheng X; Zou Y
Front Pharmacol; 2021; 12():524287. PubMed ID: 33959000
[TBL] [Abstract][Full Text] [Related]
9. Shaoyao decoction restores the mucus layer in mice with DSS-induced colitis by regulating Notch signaling pathway.
Fang YX; Liu YQ; Hu YM; Yang YY; Zhang DJ; Jiang CH; Wang JH; Zhang J
J Ethnopharmacol; 2023 May; 308():116258. PubMed ID: 36806347
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of Huangqin Decoction against ulcerative colitis and associated cancer in mice.
Chen G; Yang Y; Hu C; Cheng X; Xu Y; Cai X; Wang M; Yang CS; Cao P
Oncotarget; 2016 Sep; 7(38):61643-61655. PubMed ID: 27557503
[TBL] [Abstract][Full Text] [Related]
11. Celastrol Ameliorates Ulcerative Colitis-Related Colorectal Cancer in Mice via Suppressing Inflammatory Responses and Epithelial-Mesenchymal Transition.
Lin L; Sun Y; Wang D; Zheng S; Zhang J; Zheng C
Front Pharmacol; 2015; 6():320. PubMed ID: 26793111
[TBL] [Abstract][Full Text] [Related]
12. Shaoyao decoction improves damp-heat colitis by activating the AHR/IL-22/STAT3 pathway through tryptophan metabolism driven by gut microbiota.
Zhang Y; Han L; Dong J; Yuan Z; Yao W; Ji P; Hua Y; Wei Y
J Ethnopharmacol; 2024 May; 326():117874. PubMed ID: 38342152
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis.
Vendramini-Costa DB; Francescone R; Posocco D; Hou V; Dmitrieva O; Hensley H; de Carvalho JE; Pilli RA; Grivennikov SI
Carcinogenesis; 2017 Jan; 38(1):51-63. PubMed ID: 27797827
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics Study of Shaoyao Plants Decoction on the Proximal and Distal Colon in Mice with Dextran Sulfate Sodium-Induced Colitis by UPLC-Q-TOF-MS.
Luo Y; Wu J; Liu Y; Shen Y; Zhu F; Wu J; Hu Y
Drug Des Devel Ther; 2022; 16():4343-4364. PubMed ID: 36583115
[TBL] [Abstract][Full Text] [Related]
15. Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial-mesenchymal transition.
Huai M; Zeng J; Ge W
Int Immunopharmacol; 2021 Feb; 91():107284. PubMed ID: 33359851
[TBL] [Abstract][Full Text] [Related]
16. Over-expressed miRNA-200b ameliorates ulcerative colitis-related colorectal cancer in mice through orchestrating epithelial-mesenchymal transition and inflammatory responses by channel of AKT2.
Deng S; Wang H; Fan H; Zhang L; Hu J; Tang Q; Shou Z; Liu X; Zuo D; Yang J; Xu M; Chen Q; Dong Y; Nan Z; Wu H; Liu Y
Int Immunopharmacol; 2018 Aug; 61():346-354. PubMed ID: 29933193
[TBL] [Abstract][Full Text] [Related]
17. Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development.
Tian Y; Xu Q; Sun L; Ye Y; Ji G
J Nutr Biochem; 2018 Jul; 57():103-109. PubMed ID: 29694938
[TBL] [Abstract][Full Text] [Related]
18. Sanhuang Shu'ai decoction alleviates DSS-induced ulcerative colitis via regulation of gut microbiota, inflammatory mediators and cytokines.
Wu ZC; Zhao ZL; Deng JP; Huang JT; Wang YF; Wang ZP
Biomed Pharmacother; 2020 May; 125():109934. PubMed ID: 32058214
[TBL] [Abstract][Full Text] [Related]
19. HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial-Mesenchymal Transition.
Song H; Tang X; Li X; Wang Y; Deng A; Wang W; Zhang H; Qin H; Wu L
Drug Des Devel Ther; 2020; 14():4291-4302. PubMed ID: 33116416
[TBL] [Abstract][Full Text] [Related]
20. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
